Search

everythinglearnresearchcommunity

for

Search:↓

Certain medications, especially Paroxetine, Tamsulosin, and Finasteride, are linked to ejaculatory disorders.

Aminoacridine and Abemaciclib, especially combined with Minoxidil, show promise for treating hair loss.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Both estrogens and androgens are important for health in both males and females.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Low testosterone can cause a heart rhythm problem in men, but fixing it can prevent the issue.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

New therapies are being developed that target integrin pathways to treat various diseases.

Enhancers and super-enhancers are key in controlling specific gene activity and can play a role in cancer development.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Adding a second method to PROTACs could improve cancer treatment.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

A plant protein biostimulant improved growth, photosynthesis, and nutrient content in hydroponically grown basil.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Genes linked to wool fineness in sheep have been identified.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.